Showing results (91-100 of 887) with videos related to
Sort By:
Pageof 89
Nephrologie & Therapeutique|August 10, 2006
Lessons learnt from the 4D trialChristoph Wanner, Vera KraneAnnals of Internal Medicine|December 11, 2013
Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guidelineMarcello Tonelli, Christoph Wanner, Innere Medizin (Heidelberg, Germany)|November 13, 2023
[Kidney diseases in type 2 diabetes mellitus : Overview and implementation of guidelines, position papers and practical recommendations for diagnostics and monitoring]Monika Kellerer, Christoph WannerKidney & Blood Pressure Research|June 22, 2011
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitusChristoph Wanner, Vera KraneDeutsche Medizinische Wochenschrift (1946)|June 5, 2019
[Diabetic Kidney Disease - How to Protect the Kidney?]Susanne Brenner, Christoph WannerAnasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|September 16, 2016
[Organ replacement therapy - renal replacement therapy in intensive care medicine]Daniel Kraus, Christoph WannerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patientsChristoph Wanner, Vera KraneNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
The metabolic burden of diabetes and dyslipidaemia in chronic kidney diseaseVera Krane, Christoph WannerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patientsChristoph Wanner, Thomas MetzgerPageof 89